Viewing Study NCT07123350

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-05-28 @ 3:34 PM
Study NCT ID: NCT07123350
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2025-08-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
Sponsor: Vanderbilt University Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Inflammatory Bowel Disease (IBD) View
None Crohn&Amp;#39;s Disease (CD) View
None Ulcerative Colitis (UC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Inflammatory Bowel Disease View
None Health-system Specialty Pharmacy View
None Vedolizumab View